CURRICULUM VITAE
Amy Moskop MD
Amy Moskop MD
Assistant Professor
Department of Pediatrics
Division of Pediatrics Hematology Oncology Blood and Marrow Transplant
Department of Pediatrics
Division of Pediatrics Hematology Oncology Blood and Marrow Transplant
OFFICE ADDRESS: |
999 N. 92nd Street |
Milwaukee, WI 53226 |
EDUCATION: |
08/2006 - 05/2010 BS, Honors Degree in Biochemistry, Rockhurst University, Kansas City |
08/2010 - 05/2014 MD, Saint Louis University School of Medical College, St. Louis, MO |
06/2018 - 05/2020 MS, Clinical and Translational Science, Medical College of Wisconsin, Milwaukee |
01/2019 - 05/2019 Certification, Team Science in Clinical Research, Medical University of South Carolina |
POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS: |
07/2014 - 06/2015 Internship, Department of Pediatrics, SSM Health Cardinal Glennon Children's Hospital, Saint Louis University School of Medicine, St. Louis, MO |
07/2015 - 06/2017 Residency, Department of Pediatrics, SSM Health Cardinal Glennon Children's Hospital, Saint Louis University School of Medicine, St. Louis, MO |
07/2017 - 06/2020 Fellowship, Oncology, Blood and Marrow Transplant, Medical College of Wisconsin, WI, Division of Pediatric Hematology, Milwaukee |
FACULTY APPOINTMENTS: |
07/2020 - 06/2021 Instructor in Bone Marrow Transplant and Cellular Therapy, Pediatrics, Hematology/Oncology/Bone Marrow Transplant, Medical College of Wisconsin, Milwaukee, WI |
07/2021 - Present Assistant Professor in Bone Marrow Transplant and Cellular Therapy, Pediatrics, Hematology/Oncology/Bone Marrow Transplant, Medical College of Wisconsin, Milwaukee, WI |
HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS: |
12/2023 - Present Program Director for Autologous Transplants and Cellular Therapy, Pediatrics, Hematology, Oncology and BMT, Medical College of Wisconsin, Milwaukee, WI |
RESEARCH ADMINISTRATIVE APPOINTMENTS: |
07/2021 - 07/2024 Scientific Director, Cellular Immunotherapy for Cancer Working Committee of the CIBMTR, CIBMTR, Milwaukee, WI |
12/2023 - Present Scientific Director for Gene Therapy, CIBMTR, Milwaukee, WI |
07/2024 - Present Scientific Director of the Morbidity, Recovery and Survivorship (MRS) - Cellular Therapy Working Committee of the CIBMTR, CIBMTR, Milwaukee, WI |
SPECIALTY BOARDS AND CERTIFICATION: |
Board Certified | Issue Date | Expiration |
American Board of Pediatrics - General Pediatrics | 10/18/2017 | None |
American Board of Pediatrics - Pediatric Hematology-Oncology | 04/07/2021 | None |
Licensure | Number | Issue Date | Expiration |
Wisconsin License | 67309-20 | 05/02/2017 | 10/31/2027 |
AWARDS AND HONORS: |
05/2013 Arnold P. Gold Humanism Honor Society, Saint Louis University School of Medicine, St. Louis, MO |
05/2014 Rodney M. Coe Distinction in Community Service, Saint Louis University School of Medicine, St. Louis, MO |
2014 Saint Louis University Endowed Scholarship |
06/2017 Dr. Benjamin H. Cohen Award, Department of Pediatrics, Saint Louis University School of Medicine, St. Louis, MO |
06/2017 Richard C. Barry Award for Excellence in Emergency Medicine, Department of Pediatrics, Saint Louis University School of Medicine, St. Louis, MO |
07/2019 - 06/2020 Chief Fellow, Division of Hematology, Oncology and Marrow Transplant, Medical College of Wisconsin, Milwaukee, WI |
07/2020 - 07/2021 James Casper Pediatric Blood and Marrow Transplant & Research Fellow |
MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES: |
2013 - Present Arnold P. Gold Humanism Honor Society (Member) |
2017 - Present American Society of Hematology |
2017 - Present Children’s Oncology Group |
2019 - Present Pediatric Transplantation and Cellular Therapy Consortium |
2020 - Present American Society for Transplantation and Cellular Therapy |
EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS: |
Journal Review |
Blood Advances |
Journal of Pediatric Hematology Oncology |
OncoTargets and Therapy |
Translational Pediatrics |
Blood |
Frontiers in Oncology |
Frontiers in Immunology |
Blood Immunology & Cellular Therapy |
Transplantation and Cellular Therapy |
NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS: |
04/2022 - Present ASTCT 2023 AcCELLerate Forum Steering Committee Member, Invited Member, AcCELLerate Forum Steering Committee, ASTCT |
04/2022 - 11/2022 ASTCT/CIBMTR 2022 AcCELLerate Forum Steering Committee Member, Invited Member, AcCELLerate Forum Steering Committee, ASTCT |
09/2022 - Present Invited Steering Committee Member, Insights in Pediatric CAR T-cell Immunotherapy: Recent Advances and Future Directions (INSPIRED) Symposium |
11/2023 - Present Lead, Ex Officio, CIBMTR Adoptive Cellular Therapy (ACT) Stakeholders Council, CIBMTR |
04/2024 - Present Appointed Member, Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Immune Effector Cell Therapy (IEC) Working Group |
09/2024 - Present Invited Member, Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard – Long-Term Follow-Up Working Group |
09/2024 - Present Invited Steering Committee Member, Insights in Pediatric CAR T-cell Immunotherapy: Recent Advances and Future Directions (INSPIRED) 2025 Symposium |
RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
INVITED LECTURES/WORKSHOPS/PRESENTATIONS: |
International |
Moskop A, Pediatric ALL, Clinical Research Professionals/Data Management Track, Invited Speaker at Tandem Meetings, Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, Salt Lake City, UT, 04/2022 |
Moskop A, CAR T-cell Therapy: Registry Development, Updates, and Real-World Experience, ASTCT Clinical Immersion Course, Invited Speaker at Tandem Meetings, Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, Salt Lake City, UT, 04/2022 |
Moskop A, Cellular Therapy Updates, Clinical Research Professionals/Data Management Track, Invited Speaker at Tandem Meetings, Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, Salt Lake City, UT, 04/2022 |
Moskop, A, Chair, Updates in IEC Associated Toxicity, ASTCT, CIBMTR, and NMDP/Be the Match AcCELLerate Forum, Virtual, 11/2022 |
Moskop, A, Chair, Relapse prevention and management following CAR T-cells, Insights in Pediatric CAR T-cell Immunotherapy (INSPIRED) Symposium: Recent Advances and Future Directions, Bathesda, MD, 03/2023 |
Amy Moskop, MD, MS, Strategies for Long-term Follow-up: The CIBMTR Registry Experience, Invited Speaker at The AGENT Summit: The ASTCT and Gene Therapy Summit (Patty Steinert, PhD presented on behalf of), Boston, MA, 11/2024 |
Moskop, A, Form Spotlight: Solid Tumor, Clinical Research Professionals/Data Management Track, Invited Speaker at Tandem Meetings, Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, Honolulu, HI, 02/2025 |
Moskop, A, Data Operations: Past, Present, and Future, Clinical Research Professionals/Data Management Track, Invited Speaker at Tandem Meetings, Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, Honolulu, HI, 02/2025 |
Moskop, A, Overview of CIBMTR’s Approach to Gene Therapy Long Term Follow Up, Invited Speaker at Innovative Approaches for Gene Therapy Long-Term Follow-Up Webinar, The Multi-Regional Clinical Trials (MRCT) Center of Brigham and Women's Hospital and Harvard, Virtual, 05/2025 |
National |
Moskop A, Yan Ke, Dobrozsi S, Panepinto J, Differences in the Care of Adolescent and Young Adult (AYA) Oncology Patients Treated at a Pediatric versus an Adult Facility, Selected for Oral Abstract Presentation at Translational Science 2020, Washington, D.C., 04/16/2020 |
Schultz LM, Baggott C, Prabhu S, Pacenta H, Phillips CL, Rossoff J, Stefanski H, Talano J, Moskop A, Margossian SP, Verneris MR, Myers GD, Karras N, Brown PA, Qayed M, Hermiston M, Satwani P, Krupski C, Keating A, Wilcox R, Rabik CA, Fabrizio V, Kunicki M, Chinnabhandar V, Goksenin AY, Curran KJ, Mackall CL, Laetsch TW, Disease Burden Impacts Outcomes in Pediatric and Young Adult B-Cell Acute Lymphoblastic Leukemia after Commercial Tisagenlecleucel: Results from the Pediatric Real World CAR Consortium (PRWCC), Oral Presentation at American Society of Hematology Annual Meeting, Virtual, 12/2020 |
Moskop A, Breese E, Guest E, Pommert L, Baggott C, Prabhu S, Pacenta H, Phillips CL, Rossoff J, Stefanski H, Talano J, Moskop A, Margossian SP, Verneris MR, Myers GD, Karras N, Brown PA, Qayed M, Hermiston M, Satwani P, Krupski C, Keating A, Wilcox R, Rabik CA, Fabrizio V, Kunicki M, Chinnabhandar V, Goksenin AY, Curran KJ, Mackall CL, Laetsch TW, Schultz LM, Real-World Use of Tisagenlecleucel in Infant Acute Lymphoblastic Leukemia: Results from the Pediatric Real World CAR Consortium (PRWCC), Oral Presentation at Transplantation and Cellular Therapy Meetings (TCT), Virtual, 02/2021 |
Stefanski H, Baggott C, Prabhu S, Pacenta H, Phillips CL, Rossoff J, Talano J, Moskop A, Margossian SP, Verneris MR, Myers GD, Karras N, Brown PA, Qayed M, Hermiston M, Satwani P, Krupski C, Keating A, Wilcox R, Rabik CA, Fabrizio V, Kunicki M, Chinnabhandar V, Goksenin AY, Curran KJ, Mackall CL, Laetsch TW, Schultz LM, Post-Relapse Outcomes Following Tisagenlecleucel: Poor Survival, Despite Current Salvage Therapies: Results from the Pediatric Real World CAR Consortium (PRWCC), Oral Presentation at Transplantation and Cellular Therapy Meetings (TCT), Virtual, 02/2021 |
Moskop A, Leveraging the Cellular Immunotherapy Data Resource (CIDR) for the Study of CAR T Cell for ALL, Immuno-Oncology Translational Network (IOTN) Semi-Annual Steering Committee Meeting, 04/2021 |
McNerney, K, Lim, S, Dreyzin, A, Vatsayan, A, Baggott, C, Prabhu, S, Pacenta, H, Phillips, CL, Rossoff, J, Stefanski, H, Talano, J, Moskop, A, Margossian, SP, Verneris, MR, Myers, GD, Karras, N, Brown, PA, Qayed, M, Hermiston, M, Satwani, P, Krupski, C, Keating, A, Wilcox, R, Rabik, CA, Baumeister, S, Fabrizio, V, Kunicki, M, Chinnabhandar, V, Goksenin, AY, Curran, KJ, Mackall, CL, Laetsch, TW, Schultz, LM, CAR-Associated Hemophagocytic Lymphohistiocytosis (HLH) with Use of Commercial Tisagenlecleucel in the Pediatric Real World CAR Consortium (PRWCC): Risk Factors and Outcomes, Oral Presentation at Tandem Meetings, Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, Salt Lake City, UT, 04/2022 |
Guest, E, Moskop, A (presented on behalf of Guest, E), Heim, M, Yeo, A, Redondo, S, Willer, J, Agarwal, A, Pasquini M, Brown P, Real-world outcomes for pediatric patients aged <3 years with r/r all treated with tisagenlecleucel, Oral Presentation at 2022 American Society of Pediatric Hematology-Oncology Conference, Pittsburgh, PA, 05/2022 |
Moskop A, Why You Should Report, Importance of the Registry, Outcome Analysis, Invited Speaker at Mayo Clinic Updates in CAR-T Cell Therapy 2022, Virtual, 09/2022 |
Moskop A - Chair, Updates in IEC Associated Toxicity, ASTCT, CIBMTR, and NMDP/Be the Match AcCELLerate Forum, 11/2022 |
Christa Krupski, Christina Baggott, Samuel John, Kevin O. McNerney, Dhruv Bhatt, Julie Talano, Amy Moskop, Jenna Rossoff, Erin M. Hall, Vanessa A Fabrizio, Amy K. Keating, Muna Qayed, Deborah Schiff, April Leigh Rahrig, Jodi L. Skiles, Christian M. Capitini, Susanne H.C. Baumeister, Kevin J. Curran, Nicole Karras, Stacy Cooper, Rayne H Rouce, Snehit Prabhu, Stephanie Si Lim, Holly L Pacenta, Doug Myers, Michael R. Verneris, Christine L Phillips, Theodore W Laetsch, Crystal Mackall, and Liora Michal Schultz., Outcomes Following Tisagenlecleucel Reinfusion in Children and Young Adults with B-Cell Acute Lymphocytic Leukemia., Oral Presentation at Tandem Meetings, Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, Orlando, FL, 02/2023 |
Samuel John, Michael Heim, Kevin J. Curran, Erin M. Hall, Amy K. Keating, Susanne H.C. Baumeister, Sarah Nikiforow, Timothy Alan Driscoll, Amy Moskop, Kevin O. McNerney, Christine L Phillips, Michael A Pulsipher, Emily Hsieh, Rayne Rouce, Marcelo Pasquini, Ranjan Tiwari, Jennifer Willert, Roberto Ramos, Joerg Krueger, and Stephan A. Grupp., Improved Relapse-Free Survival (RFS) for Pediatric and Young Adult Patients with Relapsed or Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-ALL) and Low or Intermediate Preinfusion Disease Burden Treated with Tisagenlecleucel: Results from the CIBMTR Registry., Oral Presentation at Tandem Meetings, Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR., Orlando, FL, 02/2023 |
Moskop, A., Relapse prevention and management following CAR T-cells., Insights in Pediatric CAR T-cell Immunotherapy (INSPIRED) Symposium: Recent Advances and Future Directions., 03/2023 |
Roni Shouval, MD, PhD1, Christopher Strouse, MD2, Soyoung Kim, PhD3,4, Temitope Oloyede, MPH*, Sairah Ahmed, MD, Farrukh T. Awan, MD, Veronika Bachanova, MD, PhD, Talha Badar, MD, Pere Barba, MD, Amer M. Beitinjaneh, MD, MS*, Amanda F Cashen, Bhagirathbhai Dholaria, MBBS, Mahmoud Elsawy, MD, MSc*, Siddhartha Ganguly, MD, Praveen Ramakrishnan Geethakumari, MD, MS, Uri Greenbaum, MD, Hamza Hashmi, MD, Laquisa C. Hill, BS, MD, Michael D. Jain, MD, PhD, Tania Jain, MD, Partow Kebriaei, MD, Adam S Kittai, MD, Frederick L. Locke, MD, Premal D. Lulla, MBBS, Elena Mead, MD, Joseph P McGuirk, DO, Alberto Mussetti, Taiga Nishihori, MD, Amanda L. Olson, MD, Martina Pennisi, Miguel-Angel Perales, MD, Peter A. Riedell, MD, Wael Saber, MD, MS, Sayeef Mirza, MD, MPH, Margarida Magalhaes-Silverman, MD, Elizabeth J. Shpall, MD, Mohamed Sorror, MD, MSc, Kitsada Wudhikarn, MD, Cameron J. Turtle, MBBS, PhD, Marcelo Pasquini, MD, MS, Amy Moskop, MD., Predictors of Cytokine Release Syndrome and Neurotoxicity in Patients with Large B-Cell Lymphoma and Their Impact on Survival., Oral Presentation at ASH Conference., 12/2023 |
Roni Shouval, MD, PhD1, Christopher Strouse, MD2, Soyoung Kim, PhD3,4, Temitope Oloyede, MPH*, Sairah Ahmed, MD, Farrukh T. Awan, MD, Veronika Bachanova, MD, PhD, Talha Badar, MD, Pere Barba, MD, Amer M. Beitinjaneh, MD, MS*, Amanda F Cashen, Bhagirathbhai Dholaria, MBBS, Mahmoud Elsawy, MD, MSc*, Siddhartha Ganguly, MD, Praveen Ramakrishnan Geethakumari, MD, MS, Uri Greenbaum, MD, Hamza Hashmi, MD, Laquisa C. Hill, BS, MD, Michael D. Jain, MD, PhD, Tania Jain, MD, Partow Kebriaei, MD, Adam S Kittai, MD, Frederick L. Locke, MD, Premal D. Lulla, MBBS, Elena Mead, MD, Joseph P McGuirk, DO, Alberto Mussetti, Taiga Nishihori, MD, Amanda L. Olson, MD, Martina Pennisi, Miguel-Angel Perales, MD, Peter A. Riedell, MD, Wael Saber, MD, MS, Sayeef Mirza, MD, MPH, Margarida Magalhaes-Silverman, MD, Elizabeth J. Shpall, MD, Mohamed Sorror, MD, MSc, Kitsada Wudhikarn, MD, Cameron J. Turtle, MBBS, PhD, Marcelo Pasquini, MD, MS, Amy Moskop, MD, Real World Comparison of Efficacy and Safety of Fludarabine-Versus Bendamustine-Based Lymphodepleting Chemotherapy for CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy in Relapse/Refractory (r/r) Large B-Cell Lymphoma (LBCL), Oral Presentation at ASH Conference, San Diego, CA, 12/2023 |
Rouce, Rayne, Susanne H.C. Baumeister, MD, Kevin J. Curran, MD, Vanessa A. Fabrizio, MD, Erin M. Hall, MD, Emily M. Hsieh, MD, Nicole A. Karras, MD, Amy K. Keating, MD, Amy Moskop, MD, Marcelo C. Pasquini, MD, MS, Christine L. Phillips, MD, Michael A. Pulsipher, MD, Marja Nuortti, MS, LSc, Jennifer Willert, MD, Roberto Ramos, MD, Samuel John, MD, Stephan A. Grupp, MD, PhD, Evolution of tisagenlecleucel use for the treatment of pediatric and young adult relapsed/refractory (r/r) B-cell acute lymphoblastic leukemia (B-ALL): Center for International Blood & Marrow Transplant Research (CIBMTR) registry results, Oral Presentation at ASCO Conference, Chicago, IL, 05/2024 |
Strouse, Christopher, Amy Moskop, MD, Lin, Yi, et al., Predictors of Early Safety Outcomes with Axicabtagene Ciloleucel (axi-cel) in Patients with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL),, Oral Presentation at ASH Conference, San Diego, CA, 12/2024 |
Alaa Ali, Nausheen Ahmed, Soyoung Kim, Matthew Bye, Sayeef Mirza, Alex Gordon Sieg, Christopher Strouse, Kalyan Nadiminti, Priyanka A. Pophali, Rammurti T. Kamble, Lohith Gowda, Cameron J. Turtle, Christine L. Phillips, Marcelo C. Pasquini, Sairah Ahmed, Siddhartha Ganguly, Amy Moskop, MD, Real World Comparison of Efficacy and Safety of Fludarabine-Versus Bendamustine-Based Lymphodepleting Chemotherapy for CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy in Relapse/Refractory (r/r) Large B-Cell Lymphoma (LBCL), Oral Presentation at ASH Conference, San Diego, CA, 12/2024 |
Local |
Adolescent and Young Adult (AYA) Oncology: Do differences in care influence outcomes?, TL1 Scholars 3-Minute Thesis, Milwaukee, WI, 05/2019 |
Adolescent and Young Adults with Cancer: Caught in the Gap, TL1 Scholars 3-minute Thesis, Milwaukee WI, 05/2019 |
Morbidity and Mortality, Department of Pediatrics, Division of Hematology/Oncology/BMT Tumor Board, Milwaukee WI, 08/2019 |
Pediatric Subspecialty Dinner, Pediatric Student Association Medical College of Wisconsin, Milwaukee WI, 10/2019 |
Postmortem Review, Combined BMT and Cellular Therapy QI meeting Medical College of Wisconsin, Milwaukee WI, 10/2019 |
Moskop A, Talano J, Using Our Own Immune System for the Treatment of Leukemia. CAR T-cells: Past, Present, and Future, Pediatric Grand Rounds Children's Wisconsin, Milwaukee, WI, 10/2020 |
Clinical Dilemmas in the Real-World Use of Tisagenlecleucel for ALL: Attempting Data Drive Decisions, Department of Pediatrics Division of Hematology/Oncology/BMT Tumor Board, Milwaukee. WI, 10/2020 |
Updated Cytokine Release Syndrome Grading and Neurologic Assessments for CAR T-cell Patients, Combined BMT and Cellular Therapy QI meeting Medical College of Wisconsin, Milwaukee WI, 11/2020 |
CAR T-cell therapy: Clinical Outcomes and Statistical Considerations, Division of Biostatistics Seminar, 10/2021 |
Moskop A, Emcee, Exploring Immunotherapy in Pediatric Cancers, The Eighth Annual Pediatric Cancer Symposium at Children’s Wisconsin, Milwaukee, WI, 06/2022 |
Graft versus Host Disease, GI Division Meeting, Medical College of Wisconsin, Milwaukee, WI, 01/2023 |
Postmortem Review, Combined BMT and Cellular Therapy QI meeting, Medical College of Wisconsin, Milwaukee, WI, 04/2023 |
Complications of Transplant and ID Complications (Case Study). (Mentor to presenter: fellow, Dr. Alejandra Escobar Vasco), BMT/CT Education Series, Medical College of Wisconsin, 08/2024 |
COMMITTEE SERVICE: |
Medical College of Wisconsin |
12/2018 - 07/2020 Member, Children’s Wisconsin and Froedtert Hospital AYA Oncology Working Group, Children’s Wisconsin and Froedtert Hospital AYA, Milwaukee, WI |
2018 - 07/2020 Member, Adolescent & Young Adult Hematology/Oncology Significant Interest Group, The American Society of Pediatric Hematology/Oncology |
07/2019 - 06/2020 Member, Fellowship Program Evaluation Committee, Division of Hematology, Oncology and Marrow Transplant, Medical College of Wisconsin, Milwaukee, WI |
03/2022 - Present Division Representative, Medical College of Wisconsin Pediatric Residency Medical Education – Resident Evaluation Committee
Member, Medical College of Wisconsin |
08/2024 - Present Member, Human Gene Transfer Scientific Review Committee, Medical College of Wisconsin |
Hospital |
09/2023 - Present Member, The Infection Control Committee, Children's Hospital of Wisconsin, Milwaukee, WI |
MCW TEACHING ACTIVITIES: |
Medical Student Education |
07/2018 - Present H&P Reader for M3 Pediatric Students |
10/2019 - 06/2020 M3 Pediatric Student Core Curriculum Lecture Series |
11/2022 - Present Small Group Facilitator for Patient-based Discussion – Leukemia Pilot Session for M2 students as part of the new MCWfusion Curriculum |
01/2025 - Present MS3 Pediatric Ambulatory Rotation Preceptor in BMT Clinic |
Resident and Fellow Education |
04/2021 - Present Hematology/Oncology/BMT Inpatient Resident Education Series |
02/2022 - Present Medical College of Wisconsin Pediatric Residency BMT Rotation Evaluations Lead |
MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED: |
Clinical/Research Fellows |
2018 - 2021 Karen Chao, MD, MS, Medical College of Wisconsin, I served on her Masters Thesis Committee for her project, “Racial Disparities in Outcomes in Pediatric Patients Receiving Tisagenlecleucel”. This involved reviewing her thesis proposal, progress reports throughout her Masters program, and final thesis and presentation. Karen is now an Assistant Professor at Stanford University in the Pediatric Oncology Department. |
02/2022 - Present Alejandra Vasco Escobar, MD, Fellowship, Medical College of Wisconsin, Research Mentor for Quality Improvement Fellowship project: Vaccinations Post CAR T cell Therapy. Dr. Vasco Escobar is now an Assistant Professor in Bone Marrow Transplant and Cellular Therapy, Pediatrics, Hematology/Oncology/Bone Marrow Transplant, MCW. |
2023 - 2025 Zachary Telfer, MD, Fellowship, Medical College of Wisconsin, Current fellow at Med-Peds Infectious Diseases Fellow Physician, I served as a research advisor and member on his Scholarship Oversight Committee (SOC) for his fellowship research project related to viral infections in patients undergoing stem cell transplant using alpha beta T cell depletion. |
11/2025 - Present Omar Banat, MD, Fellowship, Medical College of Wisconsin, Current pediatric hematology-oncology fellow at MCW, I serve as his research Mentor for his fellowship project on Outcomes of Philadelphia chromosome-like B-cell acute lymphoblastic leukemia after allogeneic HCT in the pediatric population |
Residents |
2024 - Present Kate Dubrouskaya, DO, Medical College of Wisconsin, Current Pediatric Resident, I serve as a research mentor for a Case Report on 17-year-old with Resolution of Celiac Disease following allogeneic stem cell transplantation. |
2024 - Present Kelly Cotchett, MD, Medical College of Wisconsin, Current Pediatric Resident, I serve as a research Mentor for a Case Report on False Positive HIV RNA and DNA Testing Following Kymriah |
COMMUNITY SERVICE ACTIVITIES: |
2010 - 2014 Program Co-Director, Project LEAN Wellness Program, Saint Louis, MO |
06/2011 Medical Volunteer, Saint Louis University, Antigua, Guatemala |
2011 Fundraising Auction Co-Chair, Health Resources Center Free Medical Clinic, Saint Louis, MO |
2012 - 2016 Coach, Girls on the Run, St. Louis, MO |
11/2016 Medical Volunteer, Saint Louis University, Arusha, Tanzania |
07/2018 - 07/2019 Medical Volunteer, Camp One Step, Oncology Summer Camp, WI |
BIBLIOGRAPHY |
Refereed Journal Publications/Original Papers |
1. Bhandari, R, Lindley, A, Bhatla, D, Babic, A, Mueckl, K, Rao, R, Brooks, P, Geiler, V, Gross, G, Al-Hosni, M, Shenoy, S. "Awareness of Cord Blood Collection and the Impact on Banking." Pediatric Blood & Cancer, 2017; 64(7). |
2. Moskop, A, Dalrymple, A, Dolatshahi, L. "Systemic lupus erythematosus, Evans Syndrome and Neurofibromatosis: an unusual combination in pediatric case". Journal of Pediatric Hematology Oncology, 2020 May; 42(4):e244-e247. |
3. Moskop A, Pommert L, Thakrar P, Talano J, Phelan R. Chimeric antigen receptor T-cell therapy for marrow and extramedullary relapse of infant acute lymphoblastic leukemia. Pediatric Blood & Cancer. 2020;e28739. |
4. Pasquini, MC, Hu, ZH, Curran, K, Laetsch, T, Locke, F, Rouce, R, Pulsipher, MA, Phillips, CL, Keating, A, Frigault, MJ, Salzberg, D, Jaglowski, S, Sasine, JP, Rosenthal, J, Ghosh, M, Landsburg, D, Margossian, S, Martin, PL, Kamdar, MK, Hematti, P, Nikiforow, S, Turtle, C, Perales, MA, Steinert, P, Horowitz, MH, Moskop, A, Pacaud, L Yi, L, Chawla, R, Bleickardt, E, Grupp, S; Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma. Blood Adv 2020; 4 (21): 5414-5424 |
5. Johnston E, Martinez I, Davis E, Caudill C, Richman J, Brackett J, Dickens D, Kahn A, Schwalm C, Sharma A, Patel P on behalf of the POCC Consortium, Bhatia S, *Levine J, *Wolfson J (*co-senior authors). SARS-CoV-2 in Childhood Cancer in 2020: A Disease of Disparities. (Moskop, A, Member of POCC Consortium) J Clin Oncol. 2021 Dec 1;39(34):3778-3788 |
6. Rossoff, J, Baggott, C, Prabhu, S, Pacenta, H, Phillips, CL, Stefanski, H, Talano, J, Moskop, A, Margossian, SP, Verneris, MR, Myers, GD, Karras, N, Brown, PA, Qayed, M, Hermiston, M, Satwani, P, Krupski, C, Keating, A, Wilcox, R, Rabik, CA, Fabrizio, V, Kunicki, M, Chinnabhandar, V, Goksenin, AY, Curran, KJ, Mackall, CL, Laetsch, TW, Schultz, LM, Out of Specification Tisagenlecleucel Does Not Compromise Safety or Efficacy in Pediatric Acute Lymphoblastic Leukemia, Blood, 2021. |
7. Schultz, LM, Baggott, C, Prabhu, S, Pacenta, H, Phillips, CL, Rossoff, J, Stefanski, H, Talano, J, Moskop, A, Margossian, SP, Verneris, MR, Myers, GD, Karras, N, Brown, PA, Qayed, M, Hermiston, M, Satwani, P, Krupski, C, Keating, A, Wilcox, R, Rabik, CA, Fabrizio, V, Kunicki, M, Chinnabhandar, V, Goksenin, AY, Curran, KJ, Mackall, CL, Laetsch, TW, Disease Burden Impacts Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia after Commercial Tisagenlecleucel: A Pediatric Real-World CAR Consortium Report. Receptor Consortium Report. J Clin Oncol. 2021 Dec 9. |
8. Fabrizio, V. A., Mauguen, A., Boelens, J. J., Baggott, C., Prabhu, S., Placenta, H., Phillips, C. L., Rossoff, J., Stefanski, H., Talano, J., Moskop, A., Margossian, S. P., Verneris, M. R., Myers, G., Karras, N. A., Brown, P. A., Qayed, M., Hermiston, M., Satwani, P., Krupski, C., Keating, A., Wilcox, R., Rabik, C. A., Chinnabhandar, V., Kunicki, M., Goksenin, A., Mackall, C., Laetsch, T. W., Schultz, LM, Curran, K. J., Optimal fludarabine lymphodepletion is associated with improved outcomes following CAR T-cell Therapy, Blood Adv 2021. |
9. Fabrizio, V, Phillips, CL, Baggott, C, Prabhu, S, Pacenta, H, Rossoff, J, Stefanski, H, Talano, J, Moskop, A, Margossian, SP, Verneris, MR, Myers, GD, Karras, N, Brown, PA, Qayed, M, Hermiston, M, Satwani, P, Krupski, C, Keating, A, Wilcox, R, Rabik, CA, Kunicki, M, Chinnabhandar, V, Goksenin, AY, Curran, KJ, Mackall, CL, Laetsch, TW, Schultz, LM, Tisagenlecleucel Outcomes in Relapsed/Refractory Extramedullary ALL: A Pediatric Real World CAR Consortium Report, Blood Adv 2022; 6 (2): 600-610. |
10. Scheuermann A, Moskop A, Hopp A, Bone K, Drendel HM, Talano J, Harker-Murray P, Astle J. Pediatric Donor Cell Acute Lymphoblastic Leukemia Following Bone Marrow Transplant for GATA2 Mutation. J Pediatr Hematol Oncol. 2022 Mar 1. |
11. Moskop, A, Pommert, L, Baggott, C, Prabhu, S, Pacenta, H, Phillips, CL, Rossoff, J, Stefanski, H, Talano, J, Moskop, A, Margossian, SP, Verneris, MR, Myers, GD, Karras, N, Brown, PA, Qayed, M, Hermiston, M, Satwani, P, Krupski, C, Keating, A, Wilcox, R, Rabik, CA, Fabrizio, V, Kunicki, M, Chinnabhandar, V, Goksenin, AY, Curran, KJ, Mackall, CL, Laetsch, TW, Guest, E, Breese, E, Schultz, LM; Real-World Use of Tisagenlecleucel in Infant Acute Lymphoblastic Leukemia. Blood Adv 2022 |
12. Phelan R, Chen M, Bupp C, Bolon YT, Broglie L, Brunner-Grady J, Burns LJ, Chhabra S, Christianson D, Cusatis R, Devine SM, D'Souza A, Eapen M, Hamadani M, Hengen M, Lee SJ, Moskop A, Page KM, Pasquini M, Pérez WS, Riches M, Rizzo D, Saber W, Spellman SR, Stefanski HE, Steinert P, Weisdorf D, Horowitz M, Auletta JJ, Shaw BE, Arora M. Updated Trends in Hematopoietic Cell Transplantation in the United States with an Additional Focus on Adolescent and Young Adult Transplantation Activity and Outcomes. Transplant Cell Ther. 2022 Jul;28(7):409.e1-409.e10. doi: 10.1016/j.jtct.2022.04.012. |
13. Stefanski H, Eaton A, Baggott C, Rossoff J, Verneris MR, Keating AK, Prabhu S, Pacenta HL, Phillips CL, Talano JA, Moskop A, Margossian SP, Myers GD, Karras NA, Brown PA, Qayed M, Hermiston ML, Satwani P, Krupski C, Wilcox R, Rabik CA, Fabrizio VA, Chinnabhandar V, Goksenin AY, Egeler E, Mavroukakis S, Curran KJ, Mackall CL, Laetsch TW, Schultz LM. Higher doses of tisagenlecleucel associate with improved outcomes: a report from the pediatric real-world CAR consortium. Blood Adv. 2022 Aug 8:bloodadvances.2022007246. doi: 10.1182/bloodadvances.2022007246. |
14. Schultz LM, Eaton A, Baggott C, Rossoff J, Prabhu S, Keating AK, Krupski C, Pacenta H, Philips CL, Talano JA, Moskop A, Baumeister SHC, Myers GD, Karras NA, Brown PA, Qayed M, Hermiston M, Satwani P, Wilcox R, Rabik CA, Fabrizio VA, Chinnabhandar V, Kunicki M, Mavroukakis S, Egeler E, Li Y, Mackall CL, Curran KJ, Verneris MR, Laetsch TW, Stefanski H. Outcomes After Nonresponse and Relapse Post-Tisagenlecleucel in Children, Adolescents, and Young Adults With B-Cell Acute Lymphoblastic Leukemia. J Clin Oncol. 2022 Sep 15:JCO2201076. doi: 10.1200/JCO.22.01076 |
15. McNerney KO, Richards RM, Aguayo-Hiraldo P, Calkoen FG, Talano JA, Moskop A, Balduzzi A, Krajewski J, Dave H, Vatsayan A, Callahan C, Liu H, Li Y, Davis KL, Maude SL. SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report. J Immunother Cancer. 2023 Jan;11(1):e005957. doi: 10.1136/jitc-2022-005957. PMID: 36707090; PMCID: PMC9884906. |
16. McNerney KO, Si Lim S, Ishikawa K, Dreyzin A, Vatsayan A, Chen JJ, Baggott C, Prabhu S, Pacenta HL, Phillips CL, Rossoff J, Stefanski HE, Talano JA, Moskop A, Verneris MR, Myers D, Karras NA, Brown PA, Bonifant CL, Qayed M, Hermiston ML, Satwani P, Krupski C, Keating AK, Baumeister SHC, Fabrizio VA, Chinnabhandar V, Egeler E, Mavroukakis S, Curran KJ, Mackall CL, Laetsch TW, Schultz LM. HLH-like toxicities predict poor survival following use of tisagenlecleucel in children and young adults with B-ALL. Blood Adv. 2023 Mar 1:bloodadvances.2022008893. doi: 10.1182/bloodadvances.2022008893. Epub ahead of print. PMID: 36857419. |
17. Auletta JJ, Kou J, Chen M, Bolon YT, Broglie L, Bupp C, Christianson D, Cusatis RN, Devine SM, Eapen M, Hamadani M, Hengen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Perez WS, Phelan R, Riches ML, Rizzo JD, Saber W, Spellman SR, Stefanski HE, Steinert P, Tuschl E, Yusuf R, Zhang MJ, Shaw BE. Real-World Data Showing Trends and Outcomes by Race and Ethnicity in Allogeneic Hematopoietic Cell Transplantation: A Report from the Center for International Blood and Marrow Transplant Research. Transplant Cell Ther. 2023 Mar 15:S2666-6367(23)01165-X. doi: 10.1016/j.jtct.2023.03.007. Epub ahead of print. PMID: 36924931. |
18. Schultz L, Jacoby E, Lamble AJ, Maude SL, McNerney KO, Moskop A, Myers RM, Pulsipher MA, Shah NN. Introduction to the Reports from the Insights in Pediatric CAR T-cell Immunotherapy: Recent Advances and Future Directions (INSPIRED) Symposium. Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy. 2023 Jul 11. |
19. Adam J. Lamble*, Amy Moskop*, Michael A. Pulsipher, Shannon L. Maude, Corinne Summers, Colleen Annesley, André Baruchel, Lia Gore, Persis Amrolia, Nirali Shah, INSPIRED Symposium Part 2: Prevention and Management of Relapse Following CAR T-cell therapy for B-ALL, Transplantation and Cellular Therapy, 2023. |
20. Bender JD, Damodharan S, Capitini CM, Moskop A, Toner K, Vatsayan A, Talano JA, Baggott C, Schiff D, Katsanis E, Modi AJ, Quigg TC, Raikar SS, Schultz LM, Pommert L. Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas. Blood Adv. 2024 |
21. Cusatis R, Litovich C, Feng Z, Allbee-Johnson M, Kapfhammer M, Mattila D, Akinola I, Phelan R, Broglie L, Auletta JJ, Steinert P, Bolon YT, Akhtar O, Bloomquist J, Chen M, Devine SM, Bupp C, Hamadani M, Hengen M, Jaglowski S, Kaur M, Kuxhausen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Rizzo D, Saber W, Spellman SR, Stefanski HE, Tuschl E, Yusuf R, Zhan K, Flynn KE, Shaw BE. Current Trends and Outcomes in Cellular Therapy Activity in the United States, Including Prospective Patient-Reported Outcomes Data Collection in the Center for International Blood and Marrow Transplant Research Registry. Transplant Cell Ther. 2024 |
22. Barsan V, Li Y, Prabhu S, Baggott C, Nguyen K, Pacenta H, Phillips CL, Rossoff J, Stefanski H, Talano JA, Moskop A, Baumeister S, Verneris MR, Myers GD, Karras NA, Cooper S, Qayed M, Hermiston M, Satwani P, Krupski C, Keating A, Fabrizio V, Chinnabhandar V, Kunicki M, Curran KJ, Mackall CL, Laetsch TW, Schultz LM, Tisagenlecleucel utilisation and outcomes across refractory, first relapse and multiply relapsed B-cell acute lymphoblastic leukemia: a retrospective analysis of real-world patterns, EClinicalMedicine. 2023 Oct 26;65:102268. |
23. McNerney KO, Moskop A, Winestone LE, Baggott C, Talano JA, Schiff D, Rossoff J, Modi A, Verneris MR, Laetsch TW, Schultz L., Practice Preferences for Consolidative Hematopoietic Stem Cell Transplantation Following Tisagenlecleucel in Children and Young Adults with B Cell Acute Lymphoblastic Leukemia, Transplant Cell Ther. 2024 Jan;30(1):75.e1-75.e11. |
24. Adam J. Lamble, Liora M. Schultz, Khanh Nguyen, Emily M Hsieh, Kevin McNerney, Rayne H Rouce, Rebecca A Gardner, Sara Ghorashian, Nirali N Shah, Shannon L. Maude, Risk of T-cell Malignancy Following CAR T cells in Children, Adolescents and Young Adults, (Moskop, A, contributor participating in global survey), Blood Adv. 2024 Jul 9;8(13):3544-3548. |
25. Talleur AC, Fabrizio VA, Aplenc R, Grupp SA, Mackall C, Majzner R, Nguyen R, Rouce R, Moskop A^ (joint last), McNerney KO^, INSPIRED Symposium Part 5: Expanding the Use of CAR T Cells in Children and Young Adults, Transplant Cell Ther. 2024 Jun;30(6):565-579. |
26. Hannah Lust, Liora M. Schultz, Soyang Kwon, Gregory W. Roloff, Ibrahim Aldoss, Christina Baggott, Samuel John, Jenna Rossoff, Kevin O. McNerney, Vanessa A. Fabrizio, Julie-An Talano, Amy Moskop, Kevin J. Curran, Christine L. Phillips, Nicole A. Karras, Susanne H.C. Baumeister, Stacy Cooper, Michelle L. Hermiston, Prakash Satwani, Muna Qayed, Sunil Sudhir Raikar, Margaret L. MacMillan, Erin M. Hall, Khanh Nguyen, Ryan D. Cassaday, Noam E. Kopmar, Vamsi K. Kota, John Mathews, Paul J Shaughnessy, Marc S. Schwartz, Abdullah Ladha, George Yaghmour, Muthu Kumaran, Veronika Bachanova, Sean I Tracy, Tamer Othman, Marlise R. Luskin, Evan C. Chen, Anjali S Advani, Nikeshan Jeyakumar, Katharine Miller, Amy Zhang, Bijal D Shah, Lori S. Muffly, Rawan G. Faramand; Real World Outcomes for Young Adult Patients Receiving CD19 CAR T-cell Therapy. Blood Adv. 2025 Jun 10;9(11):2763-2772. |
27. 27. Shouval, R, Strouse, C, Kim, S, Oloyede, T, Ahmed, S, Awan, F, Luan, D, Bachanova, V, Badar, T, Bar, M, Barba, P, Beitinjaneh, AM, Cashen, A, Dholaria, B, Elsawy, M, ∙ Ganguly, S, Geethakumari, PR, Greenbaum, U, Hashmi, H, Hill, LQ, ∙Jain, M, Jain, T, Kebriaei, P,. Kittai, AS, Locke, FL, Lulla, PD, Mead, E, McGuirk, JP, Mussetti, A, Nishihori, T, Olson, AL, Pennisi, M, Perales, MA, Riedell, PA, Saber, W, Mirza, AS. Magalhaes-Silverman, M, Shpall, EJ, Sorror, M, Wudhikarn, K, Turtle, CJ, Amy Moskop, Pasquini, MC, Cytokine Release Syndrome and Neurotoxicity Following CD19 CAR-T in B-Cell Lymphoma, Transplant Cell Ther. 2025 Jul;31(7):419-433. |
28. John S, Curran KJ, Hall EM, Keating A, Baumeister SHC, Nikiforow S, Driscoll T, Moskop A, McNerney KO, Phillips CL, Pulsipher MA, Hsieh EM, Rouce RH, Pasquini MC, Tiwari R, Willert J, Ramos RJ, Krueger J, Guest E, Grupp SA. Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry. Blood Adv. 2025 Jun 24:bloodadvances.2025015881. |
29. Spellman SR, Xu K, Oloyede T, Ahn KW, Akhtar O, Bolon YT, Broglie L, Bloomquist J, Bupp C, Chen M, Devine SM, El-Jurdi N, Hamadani M, Hengen M, Huppler AH, Jaglowski S, Kuxhausen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Perez W, Phelan R, Rizzo D, Saber W, Stefanski HE, Steinert P, Tuschl E, Visotcky A, Vogel R, Auletta JJ, Shaw BE, Allbee-Johnson M. Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy - A Report from the CIBMTR. Transplant Cell Ther. 2025 May 19:S2666-6367(25)01198-4. |
30. Naik S, Selukar S, Talleur AC, Deshpande S, Llaurador Caraballo G, Fabrizio VA, Rouce RH, Zeng XL, Vatsayan A, Rossoff J, Pacenta HL, John S, Phillips CL, Talano JM, Moskop A, Verneris MR, Myers GD, Hall EM, Karras NA, Bonifant CL, Qayed M, Bakinowski E, Keating A, Baumeister SHC, Tomilson E, Hermiston ML, Satwani P, Krupski C, Chinnabhandar V, Stefanski HE, Egeler E, Curran KJ, Laetsch TW, Mackall CL, Prabhu S, Nguyen K, Baggott C, Schultz LM, McNerney KO. Characterization and prediction of hematotoxicity in pediatric patients receiving tisagenlecuecel. Blood Adv. 2025 Jul 21:bloodadvances.2025016824. |
31. Ahmed N, Thiruvengadam S, Hamadani M, Hu ZH, Grover NS, Shadman M, Locke FL, Gerson J, Frank MJ, Budde LE, Wang ML, Kim S, Bye M, Kharfan-Dabaja MA, Sauter CS, Hematti P, Turtle CJ, Ahmed S, Moskop A, Logan BR, Nunes A, Dalton DM, Kloos IM Dr, Lee D, Xu H, Pasquini MC, Herrera AF. Real-world outcomes of brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma: a CIBMTR analysis. Blood Adv. 2025 Jul 24:bloodadvances.2024015014 |
32. Appell LE, Baggott C, Nguyen K, Prabhu S, Pacenta HL, John S, Fabrizio VA, Phillips CL, Rossoff J, Talano JM, Moskop A, Phelan R, Baumeister SHC, Verneris MR, Hall EM, Myers GD, Karras NA, Cooper S, Qayed M, Raikar SS, Winestone LE, Hermiston ML, Satwani P, Krupski C, Keating A, Friedman DN, Curran KJ, Hoover A, MacMillan ML, Ebens CL, Ramgopal A, Rahrig AL, Mackall CL, Laetsch TW, Schultz LM. Liberalizing Hospital Proximity Requirements for Children/Young Adults with Low Burden B-ALL Receiving Tisagenlecleucel. Blood Adv. 2025 Sep 30:bloodadvances.2025017012. |
33. Greenbaum U, Hashmi H, Elsawy M, Kim S, Moskop A, Oloyede T, Awan FT, Bachanova V, Badar T, Bar M, Barba P, Beitinjaneh AM, Cashen AF, Dholaria B, Farooq U, Foglesong J, Ganguly S, Hematti P, Hill LC, Jain MD, Jain T, Kebriaei P, Kittai AS, Locke FL, Lulla PD, McGuirk JP, Mead E, Mussetti A, Nishihori T, Olson AL, Pennisi M, Perales MA, Ramakrishnan Geethakumari P, Riedell PA, Saber W, Shouval R, Shpall EJ, Magalhaes-Silverman M, Strouse CS, Turtle CJ, Valluripalli A, Wudhikarn K, Pasquini MC, Ahmed S, Sorror ML. New Comorbidity Index Associated with Survival After Chimeric Antigen Receptor T Cell Therapy for Large B-Cell Lymphoma. Blood Adv. 2025 Aug 14:bloodadvances.2024015599., Ahead of print |
34. Abu-Sayeef Mirza, Chitra Hosing, Francine Foss, Soyoung Kim, Amy Moskop, Temitope Oloyede, Muhammad Bilal Abid, Aimaz Afrough, Sairah Ahmed, Talha Badar, Pere Barba, Vijaya Raj Bhatt, Valerie I. Brown, Saurabh Dahiya, Abhinav Deol, Narendranath Epperla, Siddhartha Ganguly, Natalie S. Grover, Hamza Hashmi, Shahrukh Hashmi, Peiman Hematti, Gerhard C. Hildebrandt, John M. Hill, Nasheed M. Hossain, Uroosa Ibrahim, P. Connor Johnson, Mohamed A. Kharfan-Dabaja, Maxwell M. Krem, Lazaros J. Lekakis, Richard T. Maziarz, Hemant S. Murthy, Peter A. Riedell, María Queralt Salas, Geoffrey Shouse, Christopher Strouse, Monica S. Thakar, Cameron J. Turtle, Ann Woolfrey, Kitsada Wudhikarn, Jean A. Yared, Marcelo C. Pasquini, Lohith Gowda, Impact of Age on Outcomes after CD19 CAR-T Cell Therapy for Large B-Cell Lymphomas, Blood Neoplasia, 2025 Nov,100187, Ahead of print |
Books, Chapters, and Reviews |
1. Moskop A, Talano J, Pancytopenia/Aplastic Anemia/Bone Marrow Failure. In: Kliegman R, Bordini BJ, Toth H, Basel D, eds. Nelson Pediatric Symptom-Based Diagnosis: Common Diseases and Their Mimics. Second ed. Philadelphia, PA: Elsevier; 2023. |
Abstracts |
1. Moskop, A, Dalrymple, A, Dolatshahi, L. Evans syndrome, systemic lupus erythematosus, and neurofibromatosis: an unusual combination in pediatric case, American Society of Pediatric Hematology-Oncology, Pittsburgh, PA, 05/2018. |
2. Moskop, A, Malec, L, Mechanical Hemolysis and Acquired Type 2A von Willebrand Syndrome in Patient with Congenital Heart Disease. American Society of Pediatric Hematology-Oncology; Pittsburgh, PA, 05/2018. |
3. Moskop, A, Dobrozsi, S, Panepinto, J, Comparison of Health Outcomes in Adolescent and Young Adult (AYA) Oncology Patients Treated at a Pediatric Versus Adult Facility. Association for Clinical and Translational Science - Translational Science 2019 Conference, Washington, DC, 03/2019. |
4. Moskop, A, Dobrozsi, S, Panepinto, J, Comparison of Health Outcomes in Adolescent and Young Adult (AYA) Oncology Patients Treated at a Pediatric Versus Adult Facility. 6th Annual Pediatric Cancer Symposium, Milwaukee, WI, 05/2019. |
5. Moskop, A, Yan, Ke, Dobrozsi, S, Panepinto, J, Differences in the Care of Adolescent and Young Adult (AYA) Leukemia and Lymphoma Patients Treated at a Pediatric versus an Adult Facility. CTSI Midwest Regional Research Forum, Milwaukee, WI, 10/2019 |
6. Moskop, A, Yan, Ke, Dobrozsi, S, Panepinto, J, Comparison of Health Outcomes in Adolescent and Young Adult (AYA) Oncology Patients Treated at a Pediatric Versus Adult Facility. American Society of Hematology Annual Meeting, Poster Presentation at the Annual Meeting, Orlando, FL, 12/2019. |
7. Moskop, A, Yan, Ke, Dobrozsi, S, Panepinto, J, Differences in the Care of Adolescent and Young Adult (AYA) Oncology Patients Treated at a Pediatric versus an Adult Facility. Accepted for poster presentation at the Association for Clinical and Translational Science - Translational Science 2020 Conference, Washington, DC, 04/2020 |
8. Moskop, A, Harker-Murray, P, Relapsed Hodgkin Lymphoma Successfully Treated with Targeted Immunotherapy and Chemotherapy, Accepted for poster presentation at the American Society of Pediatric Hematology-Oncology Conference, Fort Worth, TX, 05/2020 (conference cancelled) |
9. Moskop, A, Tower, R, Harker-Murray, P, Residual disease detected by PET/MRI in CNS relapse of Primary Mediastinal B Cell Lymphoma, Accepted for poster presentation at the American Society of Pediatric Hematology-Oncology Conference, Fort Worth, TX, 05/2020 (conference cancelled) |
10. Moskop, A, Phelan, R, Atallah, E, Anderson, L, Rao, S, Margolis, D, Talano, J, GVHD following tisagenlecleucel for relapsed acute lymphoblastic leukemia after allogeneic hematopoietic cell transplant. Accepted for poster presentation at the 8th Annual PTCTC Meeting at American Society of Pediatric Hematology-Oncology, Fort Worth, TX, 05/2020 (conference cancelled) |
11. Rossoff, J, Baggott, C, Prabhu, S, Pacenta, H, Phillips, CL, Stefanski, H, Talano, J, Moskop, A, Margossian, SP, Verneris, MR, Myers, GD, Karras, N, Brown, PA, Qayed, M, Hermiston, M, Satwani, P, Krupski, C, Keating, A, Wilcox, R, Rabik, CA, Fabrizio, V, Kunicki, M, Chinnabhandar, V, Goksenin, AY, Curran, KJ, Mackall, CL, Laetsch, TW, Schultz, LM, Real-World Treatment of Pediatric Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia using Tisagenlecleucel that is Out of Specification for Commercial Release, Accepted for Poster Presentation at American Society of Hematology Annual Meeting, 12/2020. |
12. Schultz, LM, Baggott, C, Prabhu, S, Pacenta, H, Phillips, CL, Rossoff, J, Stefanski, H, Talano, J, Moskop, A, Margossian, SP, Verneris, MR, Myers, GD, Karras, N, Brown, PA, Qayed, M, Hermiston, M, Satwani, P, Krupski, C, Keating, A, Wilcox, R, Rabik, CA, Fabrizio, V, Kunicki, M, Chinnabhandar, V, Goksenin, AY, Curran, KJ, Mackall, CL, Laetsch, TW, Disease Burden Impacts Outcomes in Pediatric and Young Adult B-Cell Acute Lymphoblastic Leukemia after Commercial Tisagenlecleucel: Results from the Pediatric Real World CAR Consortium (PRWCC), Accepted for Poster Presentation at American Society of Hematology Annual Meeting, 12/2020. |
13. Moskop, A, Talano, J, Verneris, MR, Baggott, C, Prabhu, S, Pacenta, H, Phillips, CL, Rossoff, J, Stefanski, H, , Margossian, SP, Myers, GD, Karras, N, Brown, PA, Qayed, M, Hermiston, M, Satwani, P, Krupski, C, Keating, A, Wilcox, R, Rabik, CA, Fabrizio, V, Kunicki, M, Chinnabhandar, V, Goksenin, AY, Curran, KJ, Mackall, CL, Laetsch, TW, Schultz, LM, Immune Reconstitution and Infections in the Real-World Use of Tisagenlecleucel in Pediatric and Young Adult Acute Lymphoblastic Leukemia, Accepted for poster presentation at Transplantation and Cellular Therapy Meetings (TCT), 2/2021. |
14. Schultz, LM, Baggott, C, Prabhu, S, Pacenta, H, Phillips, CL, Rossoff, J, Stefanski, H, Talano, J, Moskop, A, Margossian, SP, Verneris, MR, Myers, GD, Karras, N, Brown, PA, Qayed, M, Hermiston, M, Satwani, P, Krupski, C, Keating, A, Wilcox, R, Rabik, CA, Fabrizio, V, Kunicki, M, Chinnabhandar, V, Goksenin, AY, Curran, KJ, Mackall, CL, Laetsch, TW, Predictive Value of Next-generation Sequencing (NGS) following Tisagenlecleucel in Pediatric and Young Adult B-Cell Acute Lymphoblastic Leukemia, Accepted for poster presentation at Transplantation and Cellular Therapy Meetings (TCT), 2/2021. |
15. Fabrizio, V, Phillips, CL, Baggott, C, Prabhu, S, Pacenta, H, Rossoff, J, Stefanski, H, Talano, J, Moskop, A, Margossian, SP, Verneris, MR, Myers, GD, Karras, N, Brown, PA, Qayed, M, Hermiston, M, Satwani, P, Krupski, C, Keating, A, Wilcox, R, Rabik, CA, Kunicki, M, Chinnabhandar, V, Goksenin, AY, Curran, KJ, Mackall, CL, Laetsch, TW, Schultz, LM, Real-World Treatment of Pediatric Patients with Relapsed Refractory CNS B-Cell Acute Lymphoblastic Leukemia using Tisagenlecleucel, Accepted for poster presentation at Transplantation and Cellular Therapy Meetings (TCT), 2/2021. |
16. Baggott, C, Kunicki, M, Prabhu, S, Pacenta, H, Phillips, CL, Rossoff, J, Stefanski, H, Talano, J, Moskop, A, Margossian, SP, Verneris, MR, Myers, GD, Karras, N, Brown, PA, Qayed, M, Hermiston, M, Satwani, P, Krupski, C, Keating, A, Wilcox, R, Rabik, CA, Fabrizio, V, Kunicki, M, Chinnabhandar, V, Goksenin, AY, Curran, KJ, Mackall, CL, Bhatia, S, Laetsch, TW, Schultz, LM, Inferior Outcomes Among Black Childhood Acute Lymphoblastic Leukemia Patients Following Tisagenlecleucel, Accepted for poster presentation at Transplantation and Cellular Therapy Meetings (TCT), 2/2021. |
17. Curran, K. J., Fabrizio, V. A., Mauguen, A., Boelens, J. J., Baggott, C., Prabhu, S., Placenta, H., Phillips, C. L., Rossoff, J., Stefanski, H., Talano, J., Moskop, A., Margossian, S. P., Verneris, M. R., Myers, G., Karras, N. A., Brown, P. A., Qayed, M., Hermiston, M., Satwani, P., Krupski, C., Keating, A., Wilcox, R., Rabik, C. A., Chinnabhandar, V., Kunicki, M., Goksenin, A., Mackall, C., Laetsch, T. W., Schultz, LM, Fludarabine-exposure predicts disease control following CD19-specific CAR T cell (tisagenlecleucel), A report from pediatric real-world CAR Consortium, Accepted as poster presentation for 27th Annual Scientific Meeting of the International Society for Cell and Gene Therapy (ISCT), 10/2021 |
18. Pacenta, H, Schultz, LM, Baggott, C, Prabhu, S, Pacenta, H, Phillips, CL, Rossoff, J, Stefanski, H, Talano, J, Moskop, A, Margossian, SP, Verneris, MR, Myers, GD, Karras, N, Brown, PA, Qayed, M, Hermiston, M, Satwani, P, Krupski, C, Keating, A, Wilcox, R, Rabik, CA, Fabrizio, V, Kunicki, M, Chinnabhandar, V, Goksenin, AY, Curran, KJ, Mackall, CL, Laetsch, TW, Real World Treatment of Pediatric Patients with Down Syndrome and Relapsed/Refractory (R/R) B-cell Acute Lymphoblastic Leukemia (B-ALL) Treated with Tisagenlecleucel, Accepted as poster presentation at the 53rd Congress of the International Society of Pediatric Oncology, 10/2021 |
19. Barsan V, Baggott, C, Prabhu, S, Pacenta, H, Phillips, CL, Rossoff, J, Stefanski, H, Talano, J, Moskop, A, Margossian, SP, Verneris, MR, Myers, GD, Karras, N, Brown, PA, Qayed, M, Hermiston, M, Satwani, P, Krupski, C, Keating, A, Wilcox, R, Rabik, CA, Fabrizio, V, Kunicki, M, Chinnabhandar, Kunicki, M, V, Goksenin, AY, Curran, KJ, Mackall, CL, Laetsch, TW, Schultz, LM, Real World Indications for Chimeric Antigen Receptor T Cell Therapy and Referral Patterns Pediatric Patients with Relapsed or High-Risk Leukemia, Accepted as poster presentation at the 53rd Congress of the International Society of Pediatric Oncology, 10/2021 |
20. Park J, Nikiforow, S, Kim, S, Hu ZH, Moskop, A, Ahmed, S, Abid MB, Badar, T, Bredeson, C, Brown, V, Cairo, M, Díaz, M, Dholaria, B, Ganguly, S, Grover, NG, Hanna, R, Hematti, P, Kohorst, MA, Lazarus, H, Lekakis, LJ, Locke, FL, Murthy, HS, Mussetti, A, Pulsipher, MA, Qayed, M, Reshef, R, Rizzieri, DA, Salas, MQ, Savani, BB, Sharma, A, Schultz, KR, Thakar, M, Turtle, C, Yared, JA, Wagner, JL, Qiu, X, Pasquini, MC, Perales, MA, Impact of Allogeneic Hematopoietic Cell Transplantation (HCT) As Consolidation Following CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy for Treatment of Relapsed Acute Lymphoblastic Leukemia (ALL). Blood 2021; 138 (Supplement 1): 3880, Accepted for Poster Presentation at American Society of Hematology Annual Meeting, 12/2021 |
21. John, S, Pulsipher, MA, Moskop, A, Hu, ZH, Phillips, CL, Hall, EM, Margossian, SP, Nikiforow, S. Martin, PL, Oshrine, B, Keating, AK, Rouce, RH, Tiwari, R, Redondo, S, Willert, J, Agarwal, A, Pasquini, MC, Grupp, SA; Real-World Outcomes for Pediatric and Young Adult Patients with Relapsed or Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (ALL) Treated with Tisagenlecleucel: Update from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry. Blood 2021; 138 (Supplement 1): 428. Accepted for Oral Presentation at American Society of Hematology Annual Meeting, 12/2021 |
22. McNerney, K, Baggott, C, Prabhu, S, Pacenta, H, Phillips, CL, Rossoff, J, Stefanski, H, Talano, J, Moskop, A, Margossian, SP, Verneris, MR, Myers, GD, Karras, N, Brown, PA, Qayed, M, Hermiston, M, Satwani, P, Krupski, C, Keating, A, Wilcox, R, Rabik, CA, Fabrizio, V, Kunicki, M, Chinnabhandar, V, Goksenin, AY, Curran, KJ, Mackall, CL, Laetsch, TW, Schultz, LM, Chimeric Antigen Receptor (CAR)-associated Hemophagocytic Lymphohistiocytosis (HLH) with use of commercial Tisagenlecleucel in the Pediatric Real World CAR Consortium (PRWCC): Risk Factors and Outcomes, Accepted for poster presentation at upcoming Tandem Meetings of ASTCT and CIBMTR, 4/2022. |
23. Uri Greenbaum, Hamza Hashmi, Mahmoud Elsawy, Soyoung Kim, Amy Moskop, Farrukh T. Awan, Umar Farooq, Siddhartha Ganguly, Peiman Hematti, Michael D. Jain, Partow Kebriaei, Frederick L. Locke, Elena Mead, Taiga Nishihori, Amanda L. Olson, Martina Pennisi, Miguel-Angel Perales, Praveen Ramakrishnan Geethakumari, MD, Roni Shouval, Elizabeth J Shpall, Margarida Magalhaes-Silverman, Christopher Strouse, Cameron J. Turtle, Anusha Vallurupalli, Kitsada Wudhikam, Marcelo C Pasquini, Sairah Ahmed, and Mohamed Sorror, Prognostic Impact of Comorbidities on Outcomes of Patients (pts) with Relapsed or Refractory Large B-Cell Lymphoma (r/r LBCL) Treated with Chimeric Antigen Receptor T-Cell Therapy (CART), Accepted for poster presentation at upcoming American Society of Hematology Annual Meeting, 12/2022 |
24. Abu-Sayeef Mirza, Chitra Hosing, Francine M. Foss, Soyoung Kim, Amy Moskop, Temitope Oloyede, Sairah Ahmed, Peiman Hematti, Cameron J. Turtle, Marcelo C Pasquini and Lohith Gowda Impact of Age on Outcomes after CD19 Directed CAR T Cell Therapy for Large B Cell Lymphomas: Real World Experience from the Center for International Blood & Marrow Transplant Research (CIBMTR), Accepted for poster presentation at upcoming American Society of Hematology Annual Meeting, 12/2022 |
25. Anthony J Ross, Christina Baggott, Snehit Prabhu, Holly Pacenta, Christine Philips, Jenna Rossoff, Heather E Stefanski, Julie Talano, Amy Moskop, Susanne H.C. Baumeister, Michael R Verneris, Gary Douglas Myers, Nicole Karras, Muna Qayed, Michelle L. Hermiston, MD, Prakash Satwani, Christa Krupski, Amy K. Keating, Rachel Wilcox, Vanessa A Fabrizio, Vasant Chinnabhandar, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Sandra K Althouse, Shannon L. Maude, Curtis J Henry, Liora M. Schultz, and Jodi L. Skiles, Obesity Associates with Inferior Outcomes and Toxicity in Pediatric and Young Adult Patient with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Treated with Commercially Manufactured Tisagenlecleucel, Accepted for poster presentation at upcoming American Society of Hematology Annual Meeting, 12/2022 |
26. John C. Molina, Vasant Chinnabhandar, Vanessa A Fabrizio, Michael Kunicki, Holly Pacenta, Jenna Rossoff, Heather E Stefanski, Julie Talano, Amy Moskop, Michael R Verneris, Gary Douglas Myers, Nicole Karras, Christina Baggott, Muna Qayed, Michelle L. Hermiston, Prakash Satwani, Christa Krupski, Amy K. Keating, Susanne H.C. Baumeister, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Liora M. Schultz, and Stephanie M. Smith, Standard Cytogenetic Risk Stratification Is Not Predictive of CD19 CAR Outcomes and Impact of Disease Burden Varies between Cytogenetic Risk Groups, Accepted for poster presentation at upcoming American Society of Hematology Annual Meeting, 12/2022 |
27. Vanessa A Fabrizio, Kristen Miller, Christina Baggott, Snehit Prabhu, Holly Pacenta, Christine L. Phillips, Jenna Rossoff, Heather E Stefanski, Julie Talano, Amy Moskop, Susanne H.C. Baumeister, Gary Douglas Myers, Nicole Karras, Patrick A. Brown, Muna Qayed, Michelle L. Hermiston, Prakash Satwani, Christa Krupski, Rachel Wilcox, Vasant Chinnabhandar, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Amy K. Keating, Michael R Verneris, and Liora M. Schultz |
28. Kevin O. McNerney, Stephanie Si Lim, Alexandra Miller, Ernest Amankwah, Alexandra Dreyzin, Anant Vatsayan, Michelle Hermiston, Christina Baggott, Snehit Prabhu, Holly L Pacenta, Christine L Phillips, Vanessa A Fabrizio, Jenna Rossoff, Challice Bonifant, Heather E. Stefanski, Julie Talano, Amy Moskop, Michael R. Verneris, Doug Myers, Nicole Karras,Muna Qayed, Prakash Satwani, Christa Krupski, Amy K. Keating, Susanne H.C. Baumeister, Vasant Chinnabhandar, Emily Egeler, Sharon Mavroukakis, Kevin J. Curran, Crystal Mackall, Theodore W Laetsch, and Liora Michal Schultz, Clinical Characteristics and Patient Outcomes with HLH like Toxicities after CD19 Based CAR T-Cell Therapy, Poster Presentation at Tandem Meetings, Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, 2/2023 |
29. Kevin O. McNerney, Stephanie Si Lim, Alexandra Miller, Ernest Amankwah, Alexandra Dreyzin, Anant Vatsayan, Michelle Hermiston, Christina Baggott, Snehit Prabhu, Holly L Pacenta, Christine L Phillips, Vanessa A Fabrizio, Jenna Rossoff, Challice Bonifant, Heather E. Stefanski, Julie Talano, Amy Moskop, Michael R. Verneris, Doug Myers, Nicole Karras,Muna Qayed, Prakash Satwani, Christa Krupski, Amy K. Keating, Susanne H.C. Baumeister, Vasant Chinnabhandar, Emily Egeler, Sharon Mavroukakis, Kevin J. Curran, Crystal Mackall, Theodore W Laetsch, and Liora Michal Schultz, High Disease Burden and Severe Neutropenia Predict HLH Toxicity in Patients with B-Acute Lymphoblastic Leukemia (B-ALL) Treated with Tisagenlecleucel in the PRWCC |
30. Kevin O. McNerney, Amy Moskop, Lena E. Winestone, Julie Talano, Deborah Schiff, Michael R. Verneris, Theodore W Laetsch, and Liora Michal Schultz, Clinical Practice Patterns and Factors Driving Usage of Consolidative Stem Cell Transplantation Post Tisagenlecleucel, Poster Presentation at Tandem Meetings, Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, 2/2023 |
31. Fateeha Furqan, Emillie Aschenbrenner, Julie Talano, Amy Moskop, Walter Longo, Bryon D Johnson, Timothy S. Fenske, Mehdi Hamadani, and Nirav N. Shah, Clinical Characteristics and Patient Outcomes with HLH-like Toxicities after CD19 Based CAR T-Cell Therapy, Poster Presentation at Tandem Meetings, Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, 2/2023 |
32. Matthew J. Frigault, Theresa Amoloja, Lea Micaletti Burke, Rodica Morariu-Zamfir, Valkal Bhatt, Kristen Bibeau, Xiao Ying Tang, Amy Moskop, Richard T. Maziarz, and John F. DiPersio, Rates of cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome (ICANS) from Center for International Blood and Marrow Transplant Research (CIBMTR) data on US subjects (SUBJ) with lymphoma following chimeric antigen receptor T cell therapy (CAR-T). Poster Presentation at American Society of Clinical Oncology, 2023 |
33. Jonathan Bender, Sudarshawn Damodharan, Amy Moskop, Keri Toner, Anant Vatsayan, Christian Capitini, Christina Baggott, Deborah E. Schiff, Emmanuel Katsanis, Sunil S. Raikar, Julie-An M. Talano, Liora M. Schultz, and Lauren Pommert, Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas, Poster Presentation at American Society of Clinical Oncology, 2023 |
34. Daniel J. Landsburg, MD, Michael Heim, MS, Amy Moskop, MD, Stephen Ronan Foley, MD, Brian T. Hill, MD, Grant Schofield, MD, Caron A Jacobson, MD, MMSc, Samantha M. Jaglowski, MD, MPH, Frederick L. Locke, Ron Ram, MD, Peter A Riedell, Gunjan L. Shah, MD, Leslie L. Popplewell, MD, FACP, MPH, Ranjan Tiwari, Stephen Lim, Harald Jakob Maier, MD, Marta Majdan, DPhil, Marcelo Pasquini, MD, MS, Matthew J Frigault, Durable Efficacy and Manageable Safety in Patients Age ≥ 75 Years with Relapsed/Refractory Large B-Cell Lymphoma Treated with Tisagenlecleucel in the Real-World Setting, Poster presentation at upcoming American Society of Hematology Annual Meeting, 12/2023 |
35. Kevin O. McNerney, MD, MSc, Vanessa A. Fabrizio, MD, Aimee C. Talleur, MD, Stephanie Si Lim, MD, Alexandra Dreyzin, MD, Christina Baggott, PhD, Anant Vatsayan, MBBS, Jenna Rossoff, MD, Snehit Prabhu, PhD, Holly L. Pacenta, MD, Christine L Phillips, MD, Julie-An Talano, MD, Amy Moskop, MD, Michael R Verneris, MD, Douglas Myers, MD, Nicole Karras, MD, Challice L. Bonifant, MD, PhD, Muna Qayed, MD, Michelle L. Hermiston, MD, PhD, Prakash Satwani, MD, MBBS, Christa Krupski, DO, MPH, Amy Keating, MD, Susanne H.C. Baumeister, MD, Vasant Chinnabhandar, MD, MBBS, Emily Egeler, Kevin J Curran, MD, Crystal L. Mackall, MD, Theodore W. Laetsch, MD, Liora Michal Schultz, MD and Swati Naik, MBBS, Risk Factors and Outcomes for Hematotoxicity Following Tisagenlecleucel for Pediatric B-Acute Lymphoblastic Leukemia, Poster presentation at upcoming American Society of Hematology Annual Meeting, 12/2023 |
36. Daniel J. Landsburg, MD, Michael Heim, Amy Moskop, MD, MS, Stephen Ronan Foley, MD, FRCPC, Brian T. Hill, MD, PhD, Grant Schofield, MD, MSc (MED), FRCPC, Caron A. Jacobson, MD, MMSc, Samantha Jaglowski, MD, MPH, Frederick L. Locke, MD, Ron Ram, M.D., Peter A. Riedell, Gunjan L. Shah, MD MS, Leslie Popplewell, MD, FACP, Ranjan Tiwari, MSc, Stephen Lim, Harald Jakob Maier, MD, Marta Majdan, Marcelo C. Pasquini, MD, MS and Matthew J. Frigault, MD, Durable Efficacy and Manageable Safety in Patients Age ≥75 Years with Relapsed/Refractory Large B-Cell Lymphoma Treated with Tisagenlecleucel in the Real-World Setting, Poster presentation at Tandem Meetings, Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, San Antonio, TX, 2/2024 |
37. Praveen Ramakrishnan Geethakumari, MD, MS, Kitsada Wudhikarn, MD, Michael D. Jain, Anusha Vallurupalli, MD, MSc, Soyoung Kim, PhD, Temitope Oloyede, MD, MPH, CPH, Farrukh T Awan, MD, Abu-Sayeef Mirza, MD, MPH, Veronika Bachanova, MD, PhD, Talha Badar, MD, Pere Barba, Prof. Amer Beitinjaneh, MD, Amanda Cashen, MD, Dr. Bhagirathbhai Dholaria, M.B.B.S., Mahmoud Elsawy, MD, MSc, DRCPSC, Umar Farooq, MD, Jessica Foglesong9, Siddhartha MD Ganguly, MD, FACP, Uri Greenbaum, MD1, Hamza Hashmi, M.D., LaQuisa Chimere Hill, MD, Dr. Tania Jain, MD, Partow Kebriaei, MD, Adam S. Kittai, MD, Frederick L. Locke, MD, Premal D. Lulla, MD, Elena Mead, MD, Joseph P McGuirk, DO, Alberto Mussetti, MD, Taiga Nishihori, MD, Amanda L. Olson, MD, Martina Pennisi, MD, Miguel-Angel Perales, MD, Peter A. Riedel9, Wael Saber, MD, MS, Roni Shouval, Elizabeth J. Shpall, MD, Mohamed L. Sorror, MD, MSc, Christopher Sun Strouse, Cameron J. Turtle, MBBS, PhD, Marcelo C. Pasquini, MD, MS, Amy Moskop, MD, MS and Sairah Ahmed, MD, Identification of Pre-Treatment Clinical Risk Factors Predictive of Inferior Survival and Increased Risk of Treatment Failure in CD19 Chimeric Antigen Receptor T Cell Recipients with Large B Cell Lymphoma, Poster presentation at Tandem Meetings, Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, San Antonio, TX, 2/2024 |
38. Kevin Owen McNerney, MD, MSc, Vanessa A. Fabrizio, MD, MS, Aimee C. Talleur, MD, Stephanie Si Lim, MD, Alexandra Dreyzin, MD, Christina Baggott, RN, PhD, Anant Vatsayan, MD, Snehit Prabhu, PhD, Jenna Rossoff, MD, Holly L Pacenta, MD, Christine L Phillips, MD, Julie A Talano, MD, Amy Moskop, MD, MS, Michael R. Verneris, MD, Doug Myers, MD, Nicole Karras, MD, Challice L Bonifant, MD, PhD, Muna Qayed, MD, MSc, Michelle Hermiston, MD PhD, Prakash Satwani, MD, Christa Krupski, DO, MPH, Amy K. Keating, MD, Susanne H.C. Baumeister, MD, Vasant Chinnabhandar, MBBS, MD, Emily Egeler, PhD, Sharon Mavroukakis, Kevin J. Curran, MD, Crystal L. Mackall, M.D., Theodore W Laetsch, MD, Liora Michal Schultz, MD and Swati Naik, MBBS, Risk Factors for Hematotoxicity Following Tisagenlecleucel for Pediatric B-Acute Lymphoblastic Leukemia, Poster presentation at Tandem Meetings, Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, San Antonio, TX, 2/2024 |
39. Prakash Satwani, MD…Amy Moskop, MD, MS… Liora Michal Schultz, MD, Establishing Costs for Commercial Chimeric Antigen Receptor T-Cell (Tisagenlecleucel; Kymriah) in Children and Young Adult B-Cell Acute Lymphoblastic Leukemia: A Merged Analysis from the Pediatric Real-World CAR Consortium (PRWCC) and Pediatric Health Information System (PHIS), Poster presentation at Tandem Meetings, Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, San Antonio, TX, 2/2024 |
40. Zeng, Xiaopei, Soyang Kwon, Anant Vatsayan, Christina Baggott, Snehit Prabhu, Samuel John, Holly L. Pacenta, Christine L. Phillips, Jenna Rossoff, Julie-An Talano, Amy Moskop, MD, Michael R Verneris, Douglas D. Myers, Erin Marie Hall, Nicole A Karras, Challice L. Bonifant, Muna Qayed, Michelle L. Hermiston, Prakash Satwani, Christa Krupski, Amy K Keating, Susanne H.C. Baumeister, Vanessa A. Fabrizio, Vasant Chinnabhandar, Emily Egeler, Sharon Mavroukakis, Khanh Nguyen, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Liora Michal Schultz, Kevin O. McNerney; Role of B Cell Recovery in Relapse Risk and CD19 Phenotype Following Real-World Use of Tisagenlecleucel for Pediatric B-Acute Lymphoblastic Leukemia: A Multi-Institutional Retrospective Study, Poster presentation at American Society of Hematology Annual Meeting, San Diego, CA, 12/2024 |
41. Daniel J. Landsburg, Richard T. Maziarz, Amy Moskop, MD, Leslie L. Popplewell, Scott R. Solomon, Michael T. Tees, Yongzi Yu, Aiesha Zia, Stephen Lim, Avishek Pal, Pei Hsu, Frederick Locke; Efficacy and Safety of Tisagenlecleucel in Patients with Relapsed/Refractory Follicular Lymphoma: A Real-World Analysis from the Center for Blood and Marrow Transplant Research (CIBMTR) Registry, Poster presentation at American Society of Hematology Annual Meeting, San Diego, CA, 12/2024 |
42. Lauren Appell...A Moskop…Lena Winestone et al., Liberalizing Requirements for Hospital Proximity Post-CD19 CAR for Children with Low Burden B-ALL at Infusion, Poster presentation at Tandem Meetings, Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR, Honolulu, HI, 2/2025 |
